These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 25151964)

  • 41. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
    BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
    Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
    Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
    Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ
    Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
    Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
    Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
    Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
    Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.
    Azzam DJ; Zhao D; Sun J; Minn AJ; Ranganathan P; Drews-Elger K; Han X; Picon-Ruiz M; Gilbert CA; Wander SA; Capobianco AJ; El-Ashry D; Slingerland JM
    EMBO Mol Med; 2013 Oct; 5(10):1502-22. PubMed ID: 23982961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
    Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
    Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN
    Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
    Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
    Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
    Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.
    Prajapati KS; Kumar S
    J Cell Biochem; 2023 Aug; 124(8):1186-1202. PubMed ID: 37436061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.
    Chung SS; Vadgama JV
    Anticancer Res; 2015 Jan; 35(1):39-46. PubMed ID: 25550533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden.
    van der Zee M; Sacchetti A; Cansoy M; Joosten R; Teeuwssen M; Heijmans-Antonissen C; Ewing-Graham PC; Burger CW; Blok LJ; Fodde R
    Cancer Res; 2015 Sep; 75(17):3608-22. PubMed ID: 26130650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
    Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
    Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
    Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
    Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
    Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
    Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
    J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.